Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology tags : Genetown save search
Gilead Sciences Publishes 2023 ESG Impact Report
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 4.9M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
gilead report sciences impact esg
Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ALNY | News | $145.16 -0.11% -0.19% 400K
|
Health Technology
|
| O: -1.17%
H: 1.01%
C: 0.11%
first conference financial results
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024Conference call scheduled for 4:30 p.m. Eastern Time
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
ARDX | News | $6.44 -1.68% -1.63% 2.9M
|
Health Technology
|
| O: -2.97%
H: 0.61%
C: -1.38%
first report for financial results
Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
vx-548
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
Published: 2024-04-18 (Crawled : 13:00) - biospace.com/
ZLAB | News | $14.2 3.5% 3.38% 690K
|
Health Technology
|
| O: -1.24%
H: 0.0%
C: 0.0%
nuzyra pre-clinical pharmaceuticals global
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
ENTA | $13.23 -5.5% -5.82% 150K
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
presentation pharmaceuticals global
SaponiQx and InvivoGen Announce Agreement for SaponiQx to Supply Cultured Plant Cell QS-21 Adjuvant
Published: 2024-04-17 (Crawled : 13:00) - biospace.com/
AGEN | $4.97 -7.96% -8.65% 1.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
qs-21 cell for agreement
Vizgen Issued a New US Patent for Its MERFISH Technology
Published: 2024-04-16 (Crawled : 18:00) - biospace.com/
TXG | $28.96 -0.69% -0.69% 3M
|
Health Technology
|
| O: -2.62%
H: 0.57%
C: -3.75%
patent for technology
VBI Vaccines Reports Full Year 2023 Financial Results
Published: 2024-04-16 (Crawled : 14:00) - biospace.com/
VBIV | $0.6001 -1.46% -1.48% 180K
|
Health Technology
|
| O: -3.45%
H: 14.29%
C: 10.71%
year financial results
Blueprint Medicines to Host Webcast and Conference Call Highlighting Emerging Opportunities for Mast Cell-Targeted Therapeutics
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BPMC | News | $88.9 0.59% 0.58% 730K
|
Health Technology
|
| O: 1.08%
H: 1.19%
C: 0.85%
conference for therapeutics
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
VSTM | $10.23 -5.63% -6.38% 67K
|
Health Technology
|
| O: -0.4%
H: 4.84%
C: 4.79%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.05%
H: 0.0%
C: 0.0%
medical therapeutics
Black Diamond Therapeutics Announces Changes to Board of Directors - April 11, 2024
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BDTX A | $5.295 -7.11% -7.65% 1.9M
|
Health Technology
|
| O: -3.01%
H: 11.9%
C: 11.4%
therapeutics
bluebird bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
BLUE | $0.953 -1.07% -0.52% 6.2M
|
Health Technology
|
| O: 1.68%
H: 1.65%
C: -4.13%
nasdaq grants
Deciphera Pharmaceuticals to Present at the Stifel 2024 Virtual Targeted Oncology Forum
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
DCPH | $14.235 -3.3% -3.41% 760K
|
Health Technology
|
| O: -2.13%
H: 5.02%
C: 4.69%
pharmaceuticals
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.589 -6.11% -6.5% 3.8M
|
Health Technology
|
| O: -2.31%
H: 3.86%
C: -1.47%
ser-155 for trial therapeutics
Syros Receives Fast Track Designation from the FDA for Tamibarotene for the Treatment of Newly Diagnosed Unfit AML with RARA gene overexpression
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
SYRS | $4.72 -7.63% -7.35% 120K
|
Health Technology
|
| O: 2.16%
H: 23.21%
C: 16.03%
fda treatment designation for aml
Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Senior Vice President of Global Head of Biometrics
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
OCUL | News | $5.86 -22.69% -29.35% 6.1M
|
Health Technology
|
| O: -9.56%
H: 2.44%
C: 2.25%
nasdaq ocular global grants
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
ACET | $2.025 -10.79% -12.38% 930K
|
Health Technology
|
| O: -1.33%
H: 1.8%
C: -1.8%
conference
C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor
Published: 2024-04-08 (Crawled : 14:00) - biospace.com/
CCCC | $6.91 0.58% 0.58% 820K
|
Health Technology
|
| O: -1.57%
H: 0.0%
C: 0.0%
cft1946 approved preclinical for therapeutics
BPGbio Presents Key Advances in its Oncology Pipeline related to the NAi Interrogative Biology Platform
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
pipeline key platform
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.52 100.0% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.15 63.21% 37.74% 16M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.